FDA Inspection 1206781 — Advanced Reproductive Medicine & Gynecology Of Hawaii, Inc.
The FDA completed an inspection of Advanced Reproductive Medicine & Gynecology Of Hawaii, Inc. on May 4, 2023 in Honolulu, HI. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 4, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Honolulu, HI (United States)